Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases

Allogeneic blood or marrow transplantation (BMT) is potentially curative for a variety of life-threatening nonmalignant hematologic diseases such as paroxysmal nocturnal hemoglobinuria (PNH) and hemoglobinopathies. The application of BMT to treat these disorders is limited by the lack of suitable do...

Full description

Saved in:

Bibliographic Details
Main Authors:	Brodsky, RA, Luznik, L, Bolaños-Meade, J, Leffell, MS, Jones, RJ, Fuchs, EJ
Format:	Artigo
Language:	Inglês
Published:	2008
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3086163/ https://ncbi.nlm.nih.gov/pubmed/18622413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2008.203
Tags:	Add Tag No Tags, Be the first to tag this record!

Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases

Similar Items